Journal
CANCER LETTERS
Volume 306, Issue 2, Pages 214-222Publisher
ELSEVIER IRELAND LTD
DOI: 10.1016/j.canlet.2011.03.009
Keywords
Hepatocellular carcinoma; Orthotopic liver transplantation; FOXM1; Biomarker
Categories
Funding
- Ministry of Health, Beijing, China [2008BAI60B03]
Ask authors/readers for more resources
Molecular biomarker has been proposed to improve patient selection and post-transplant prognostication, but rare achievement has been made. In the present study, Forkhead box M1 (FOXM1) expression and its prognostic role have been investigated in hepatocellular carcinoma (HCC) treated by orthotopic liver transplantation (OLT). We found that the notably higher level of FOXM1 in tumors was associated with malignant pathological features of HCC and unfavorable outcome after OLT. The status of FOXM1 expression combined with the Milan criteria could make the prognostication more accurate and may be of particular interest for expanding the criteria in selecting transplant candidates. (C) 2011 Elsevier Ireland Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available